← 483 OBSERVATION EXPLORER

FDA 483 OBSERVATION · #912 OF 1,000 MOST-CITED

Written procedures - returned dietary supplement; destroyed

FDA cited this observation 16 times across 16 firms in recent inspections. Below: how it breaks down by program area and fiscal year, and real examples of how FDA worded it on Form FDA 483.

BY PROGRAM AREA
Foods16
BY FISCAL YEAR
FY20231
FY20211
FY20202
FY20193
FY20184
FY20175

How FDA worded it — real examples

You did not establish written procedures for when a returned dietary supplement must be destroyed, or otherwise suitably disposed.

Icecube Herbals, LLC · Remer, Minnesota · Foods · 2023-08-03

You did not establish and follow written procedures for when a returned dietary supplement must be destroyed, or otherwise suitably disposed.

Bea Lydecker's Naturals Inc · Oregon City, Oregon · Foods · 2021-06-24

You did not establish written procedures for when a returned dietary supplement must be destroyed, or otherwise suitably disposed.

Inverelle dba Ultra-Life, Inc. · Carlyle, Illinois · Foods · 2020-02-05

You did not establish and follow written procedures for when a returned dietary supplement must be destroyed, or otherwise suitably disposed.

BHP Holdings Inc · Woodinville, Washington · Foods · 2019-11-08

You did not establish written procedures for when a returned dietary supplement must be destroyed, or otherwise suitably disposed.

Rico-Perez Products, Inc. · Coral Gables, Florida · Foods · 2019-08-14

You did not establish written procedures for when a returned dietary supplement must be destroyed, or otherwise suitably disposed.

General Nutrition Centers, Inc. · Phoenix, Arizona · Foods · 2019-02-04

Related SPEQ references

Where to read the requirements behind this observation area on SPEQ. These are SPEQ's topic and audience pages — not an FDA classification of the citation.

Pharmaceutical quality systemFood industry

Examples are a representative sample of FDA's published inspection observations. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →